X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4880) 4880
Publication (233) 233
Newsletter (60) 60
Magazine Article (56) 56
Newspaper Article (55) 55
Book Review (37) 37
Book Chapter (15) 15
Dissertation (9) 9
Conference Proceeding (5) 5
Book / eBook (3) 3
Government Document (2) 2
Reference (2) 2
Streaming Video (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2410) 2410
male (2363) 2363
animals (1939) 1939
fenfluramine (1925) 1925
fenfluramine - pharmacology (1627) 1627
female (1526) 1526
rats (1501) 1501
serotonin (1133) 1133
adult (1074) 1074
pharmacology & pharmacy (960) 960
d-fenfluramine (859) 859
neurosciences (829) 829
psychiatry (761) 761
middle aged (691) 691
fenfluramine - therapeutic use (690) 690
fenfluramine - adverse effects (595) 595
serotonin - metabolism (575) 575
obesity - drug therapy (551) 551
serotonin - physiology (466) 466
dose-response relationship, drug (433) 433
index medicus (413) 413
time factors (413) 413
obesity (401) 401
dexfenfluramine (379) 379
rats, sprague-dawley (362) 362
appetite depressants - adverse effects (353) 353
prolactin - blood (321) 321
eating - drug effects (308) 308
fenfluramine - administration & dosage (305) 305
appetite depressants - pharmacology (295) 295
brain - metabolism (279) 279
mice (274) 274
rats, inbred strains (274) 274
serotonin uptake inhibitors - pharmacology (272) 272
adolescent (267) 267
body weight - drug effects (264) 264
fenfluramine - analogs & derivatives (258) 258
prolactin (258) 258
brain (251) 251
brain - drug effects (251) 251
double-blind method (249) 249
endocrinology & metabolism (245) 245
medicine, general & internal (245) 245
fluoxetine (238) 238
food-intake (233) 233
feeding behavior - drug effects (230) 230
rat (229) 229
phentermine (228) 228
aged (226) 226
appetite depressants - therapeutic use (216) 216
5-ht (213) 213
receptors, serotonin - drug effects (213) 213
clinical neurology (207) 207
dopamine (206) 206
amphetamine (192) 192
heart valve diseases - chemically induced (192) 192
5-hydroxytryptamine (191) 191
serotonin antagonists - pharmacology (187) 187
drugs (185) 185
child (179) 179
behavioral sciences (177) 177
hydrocortisone - blood (175) 175
receptors (174) 174
clinical trials as topic (172) 172
phentermine - adverse effects (172) 172
depression (170) 170
dextroamphetamine - pharmacology (167) 167
nutrition & dietetics (167) 167
serotonin receptor agonists - pharmacology (164) 164
food intake (163) 163
weight loss (161) 161
drug interactions (159) 159
behavior (155) 155
body-weight (155) 155
rat-brain (155) 155
amphetamine - pharmacology (152) 152
in vitro techniques (150) 150
risk factors (150) 150
serotonin agents - pharmacology (148) 148
drug therapy (146) 146
analysis of variance (145) 145
fluoxetine - pharmacology (142) 142
rats, wistar (141) 141
cortisol (140) 140
behavior, animal - drug effects (139) 139
appetite depressants (138) 138
dopamine - metabolism (136) 136
body weight (134) 134
cardiac & cardiovascular systems (134) 134
major depression (134) 134
brain chemistry - drug effects (132) 132
hypertension, pulmonary - chemically induced (132) 132
research (129) 129
piperazines - pharmacology (128) 128
anorexia (126) 126
release (124) 124
placebos (122) 122
motor activity - drug effects (121) 121
neurotoxicity (120) 120
receptors, serotonin - physiology (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4772) 4772
French (113) 113
German (53) 53
Italian (27) 27
Spanish (27) 27
Japanese (14) 14
Chinese (12) 12
Danish (10) 10
Portuguese (8) 8
Czech (6) 6
Dutch (6) 6
Russian (6) 6
Hebrew (5) 5
Norwegian (4) 4
Polish (4) 4
Turkish (3) 3
Korean (2) 2
Swedish (2) 2
Croatian (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological Psychiatry, ISSN 0006-3223, 05/2017, Volume 81, Issue 10, pp. S268 - S269
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 01/2007, Volume 356, Issue 1, pp. 6 - 9
Journal Article
Neuroscience Letters, ISSN 0304-3940, 11/2018, Volume 687, p. 43
Multiple laboratories have shown that the stimulation of [mu]-opioid receptors in the nucleus accumbens (NAcc) powerfully increases intake of palatable and... 
Serotonin | Hallucinogenic drugs | Fenfluramine
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2017, Volume 81, Issue 10, pp. S268 - S269
Journal Article
Journal Article
1997, ISBN 0125181701, xv, 126
Redux is a revolutionary new anti-obesity drug that has just been approved (July 1996) by the FDA. It is the first weight management drug treatment to be... 
Obesity | Chemotherapy | Dexfenfluramine | Medicine: General Issues
Book
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e38273
Journal Article
Brain Research, ISSN 0006-8993, 02/2002, Volume 928, Issue 1-2, pp. 30 - 39
The mechanisms by which fenfluramine suppresses food intake and body weight have been linked to its ability to enhance transmission across serotonin synapses... 
fenfluramine
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 12/2010, Volume 19, Issue 12, pp. 1256 - 1262
Purpose To evaluate and quantify in diabetic patients treated with benfluorex in France, a fenfluramine‐derivated product, a possible increase in risk of... 
benfluorex | adverse effects | valvular heart disease | health insurance system | reimbursement databases | pharmacoepidemiology | Pharmacoepidemiology | Valvular heart disease | Reimbursement databases | Adverse effects | Benfluorex | Health insurance system | APPETITE-SUPPRESSANT DRUGS | DATABASES | RISK | 5-HT2B RECEPTORS | FRANCE | PHARMACOLOGY & PHARMACY | PATIENT | FENFLURAMINE | Appetite Depressants - adverse effects | Heart Valve Diseases - pathology | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Risk | Appetite Depressants - therapeutic use | Mitral Valve Insufficiency - epidemiology | Medical Record Linkage - methods | Pharmacoepidemiology - methods | Heart Valve Diseases - epidemiology | Aortic Valve Insufficiency - chemically induced | Heart Valve Diseases - chemically induced | Adult | Female | Databases, Factual | Fenfluramine - therapeutic use | Mitral Valve Insufficiency - chemically induced | France - epidemiology | Fenfluramine - analogs & derivatives | Diabetes Mellitus - drug therapy | Fenfluramine - adverse effects | Heart Valve Prosthesis Implantation - statistics & numerical data | Aged | Aortic Valve Insufficiency - epidemiology | Cohort Studies | Side effects | Historical account | Diabetes mellitus | Insurance | Surgery | Gender | Cardiovascular diseases | Heart diseases | Age
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 4, pp. 1 - 5
Background: Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is... 
CARDIAC-VALVE REGURGITATION | OBESE-PATIENTS | APPETITE-SUPPRESSANT DRUGS | BIOLOGY | RISK | PREVALENCE | FENFLURAMINE | DOPAMINE AGONISTS | Single-Blind Method | Hypolipidemic Agents - adverse effects | Mitral Valve Insufficiency - chemically induced | Fenfluramine - analogs & derivatives | Humans | Middle Aged | Male | Fenfluramine - adverse effects | Heart Valve Diseases - etiology | Case-Control Studies | Heart Valve Diseases - chemically induced | Female | Aged | Retrospective Studies | Mitral Valve Insufficiency - etiology | Odds Ratio | Heart valve diseases | Obesity | Diabetics | Medical research | Genetic disorders | Endocarditis | Medicine, Experimental | Cardiology | Drugs | Heart | Physicians | Cardiomyopathy | Body weight | Radiation | Parkinsons disease | Dyslipidemia | Clinical trials | Fenfluramine | Cardiovascular disease | Family medical history | Body mass index | Vasculitis | Surgery | Regurgitation | Rheumatic heart disease | Heart diseases | Interviews | Medical personnel | Hypertension | Radiation effects | Dopamine | Diabetes mellitus | Case reports | Disease control | Patients | Trauma | Coronary artery disease | Hospitals | Body mass | Amphetamines | Diagnostic systems | Diabetes | Hypolipidemic Agents | Heart Valve Diseases | Life Sciences | Human health and pathology | Mitral Valve Insufficiency
Journal Article